-
Wedbush Reiterates Outperform Rating for Day One Biopharmaceuticals (NASDAQ:DAWN)
Source: Buzz FX / 26 Feb 2025 10:21:19 America/Chicago
Wedbush Reiterates Outperform Rating for Day One Biopharmaceuticals (NASDAQ:DAWN) Written by MarketBeat February 26, 2025 Share Link copied to clipboard. Day One Biopharmaceuticals ( NASDAQ:DAWN - Get Free Report ) 's stock had its "outperf
Read more...